Sudarshan Pharma's CFO Sachin Mehta resigned effective May 1, 2026, with no material reasons provided.
The resignation disclosure was made to BSE under SEBI LODR Regulation 30 on May 1, 2026.
Mehta will continue serving as the company's Joint Managing Director post his CFO resignation.
The company submitted the resignation letter to BSE in response to a query for additional details.